Describe the suboptimal outcomes associated with conventional monoaminergic antidepressants in MDD/TRD Assess the treatment limitations associated with conventional monoaminergic antidepressants in MDD and TRD Evaluate the mechanism of action and latest clinical and real-world evidence and treatment implications associated with newer glutamatergic and neuromodulation therapies for TRD Develop personalized treatment plans for patients with TRD according to the latest guidelines and the principles of patient-centered care and shared decision-making
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
MOC types
FDA REMS
Qualifies for MIPS
Target Specialties
Address:
- 104 Windsor Center Drive
Pricing
CME included with membership · $99–598/yr
| New Membership – Standard | $349/yr |
| New Membership – Standard (2-year) | $598/yr |
| New Membership – Military/VA | $259/yr |
| New Membership – Student/Resident | $149/yr |
| Renewal Membership – Standard | $249/yr |
| Renewal Membership – Standard (2-year) | $478/yr |
+27 more tiers
Collected from the provider’s public pages · source
Specialties served/covered
- Child & Adolescent Psychiatry
- Clinical Informatics
- Communication & Shared Decision-Making
- General & Adult Psychiatry
- General Surgery
- Interventional Radiology
- Mood & Anxiety Disorders
- Neurology
- Neuroradiology
- Nuclear Medicine
- Pain Medicine
- Pediatric Neurology
- Practice Management & Ethics
- Psychopharmacology
- Psychotic Disorders
- Sleep Medicine
- Cross-Specialty
- Medical Subspecialties
- Neurology
- Pain & Palliative
- Psychiatry
- Radiology
- Surgery
- No reviews yet. Be the first to share yours.
Pricing
Free
Reported to ACCME by the provider
- On-demand / recorded video
- Credit · Up to 1.25 credits
- MOC · Up to 1.25 points
- Commercial Support
-
ReleasedOct 30, 2025
-
Last day to claim creditOct 31, 2026 3 weeks left
-
HMP Education Novel Strategies for Treatment-Resistant Depression : Understanding the Utility of Glutamatergic Antidepressants
-
Neuroscience Education Institute +1 Fast and Curious: Exciting Advances in the Rapid-Acting and Targeted Treatment of Major Depressive Disorder
-
HMP Education Aiming Higher in MDD: Practical Strategies and Novel Monotherapies to Improve Outcomes
